Important work by Dr. Winthrop on influenza AEs in Tofacinitib patients - similar among 5mg/10mg BID, only 2 deaths/~500 cases, both with H1N1 and co-morbid RFs. Abst#L04 @RheumNow #ACR20 https://t.co/7MZYGv8W3i

Do you have a problem with no-shows? #ABS1584 discusses telemedicine and care access during COVID-19. Case Western observed a 0% cancellation rate, <10% no-show rate, & 90% of scheduled telemed visits completed during COVID-19. #ACR20 #ACRbest @RheumNow https://t.co/uxzpfELDBG https://t.co/U2qrOTJZOq

• Risk Factors for Adverse Pregnancy Outcomes in Women with Spondyloarthritis: An…

Abst#L01. Pt is on MTX/ADA for RA and asks you about their COVID risk. What do you counsel your patient? #ACR20 @RheumNow.

I just reviewed the #ACR20 talk regarding vaccination. Highly recommended/timely given data released from Pfizer today regarding the COVID-19 vaccine trial. ⁦@RheumNow⁩ Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective - The New York Times https://t.co/Fb5ZepCBeJ

• https://www.nytimes.com/2020/11/09/health/covid-vaccine-pfizer.html

Dr. Bermas presented #GRA data on 14 rheumatic Pregnant women w/ COVID-19 w/ good outcomes (4 hospitalized & no deaths) but MMWR just reported preg COVID may have worse outcomes. https://t.co/6SD6Rzbxwx https://t.co/C4QS23axfN

• https://meet.acrconvergence.org/meetings/virtual/4o5PLJiNth8w6kZE2
• https://www.cdc.gov/mmwr/volumes/69/wr/mm6944e2.htm?s_cid=mm6944e2_e&ACSTrackin…

The @rheum_covid experience with patients with rheumatic disease who are *pregnant* and get COVID-19 is being presented by Bonnie Bermas from UTSouthwestern #ACR20 Sunday 3pm Eastern https://t.co/eeKqMXgpFx

• COVID-19 in Pregnant Patients with Rheumatic Disease: Data from the COVID-19 Gl…

A Convergence of Ideas: COVID19 and ACR by Dr. Kathryn Dao (@KDAO2011) #ACR20 https://t.co/0Rxv9GjOkw https://t.co/2uOiOZfSfM

• https://bit.ly/2IfFZFL

@RetamozoSole @RheumNow @Reumaclinic @MAS_Clinic @hospitalclinic #ACR20 Thanks for sharing! but our data show that patients under anti-Cytokine therapy in monotherapy at baseline (specifically anti-IL6 -IL12/23 and -IL17) or under JAKinh were ⬇️LESS likely to be admitted (OR 0.15; 95% CI 0.03-0.66; p=0.012) 📍Limitations: small number of pts https://t.co/zeLzrNLeDQ

Awesome #COVID19 vaccine round table tonight at #ACR20 @LCalabreseDO @ACRheum @HealioRheum @RheumNow https://t.co/a6jwDHc95v

Dan Barouch: The #COVID19 has advantage of known spike protein which is a natural target for vaccination. HIV by contrast does not have such an obvious target. #ACR20 @RheumNow

COVID-19 changes everything, but our vasculitis patients particularly have had some really difficult decisions to make. @VasculitisFound @michaelgeorgemd @maferradastrong @petercgrayson @RADoctor @DrPeterMerkel et al #ACR20 ABST1416 @RheumNow https://t.co/lWXtgSqDqy